Global HIV Diagnostics and Treatment Market 2019-2025
発行: Orion Market Research Pvt Ltd
Global HIV Diagnostics and Treatment
Market Size, Share & Trends Analysis Report by Test Type (Antibody Test, Viral Identification Assays, CD4 Testing, Viral Load Testing, and Early Infant Diagnostics), by Diagnostic Product (Kits and Reagents, and Instruments), by Treatment (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS), Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS), Integrase Inhibitors, and Others), and by End-User (Diagnostic Laboratory, Hospitals, Home Care Settings, Blood Bank, and Others) and Forecast 2019-2025.
The global HIV diagnostics and treatment market is expected to grow at a CAGR of 7.6% during the forecast period. The HIV impact on the immune system of human body weakens the patient's defense system against any infections. It attacks and destroys white blood cell and T-helper cell. Progressively the immune system becomes vulnerable to any kind of infections. The market for HIV is growing considerably owing to increasing occurrence of HIV/AIDS infection around the globe. The government is taking initiatives for diagnosis and treatment, blood transfusions, and is significantly working on rising awareness regarding HIV/AIDS. The major factors that are responsible for the rising number of HIV infection includes lifestyle changes, unsafe injection drug usage and lack of awareness.
Geographically, the global aluminum foil market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the global HIV diagnosis and treatment market due to the significant R&D activities for HIV/AIDS diagnosis and treatment. Regional government is taking initiatives for the ongoing diagnostic efforts for development of new treatment and products. Asia-Pacific is anticipated to grow at considerable pace in the global market during the forecast period. The partnerships among the western market players and the government in the region are major factors that are fueling the growth of HIV diagnosis and treatment market in the region.
The main players functioning in the global HIV diagnosis and treatment market include Bristol-Myers Squibb Co., Merck & Co., Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., bioMerieux SA, Gilead Sciences, Inc., Siemens AG, Sysmex Corp., and ViiV Healthcare. These players are playing a significant role in the growth of the HIV diagnosis and treatment market by providing various products and adopting several strategies such as a merger and acquisition, partnerships, collaboration, R&D; among others.
The market study of the global HIV diagnostics and treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.
The report is intended for HIV diagnostics and treatment market players, pharmaceutical companies, research institutes, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.